+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cystic pancreatic neuroendocrine tumors: A more favorable lesion?

Cystic pancreatic neuroendocrine tumors: A more favorable lesion?

Pancreatology 2019

Pancreatic neuroendocrine tumors (PNETs) are predominantly solid lesions with malignant potential. Cystic PNETs are a small subset in which data are scarce. The aim of this study was to compare clinical and biologic differences between cystic and solid PNETs. Patients with PNETs undergoing pancreatectomy between 1988 and 2016 at a high-volume center were reviewed retrospectively. Demographic, clinical, and histopathologic data were collected and analyzed. 347 patients with PNETs were identified; 27% (n = 91) were cystic. Patients with cystic PNETs were generally older (59 vs. 55 years, p = 0.05). Cystic PNETs were more commonly non-functional (95% vs. 82%, p = 0.004), asymptomatic (44% vs. 28%, p = 0.009), and located in the pancreatic body/tail (81% vs. 60%, p < 0.001) than solid PNETs. Although cystic and solid PNETs had similar sizes and pathologic stage at the time of resection, Ki-67 proliferation index (Ki-67 ≤ 9%: 98% vs. 85%; p = 0.007), and histologic grade (grade I: 84% vs. 59%; p = 0.009) had less aggressive features in cystic PNETs. In addition to reporting a higher than previously published incidence of cystic PNET (27%), this study found significant differences in multiple clinicopathologic variables between cystic and solid PNETs. Cystic PNET may be a distinct and possibly less aggressive subtype of PNET yet have similar pathologic stage, recurrence, and survival to solid PNETs. Cystic PNETs require further attention to better understand the true natural history.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066446910

Download citation: RISBibTeXText

PMID: 30704851

DOI: 10.1016/j.pan.2019.01.017

Related references

Cystic pancreatic neuroendocrine tumors: a more favorable lesion?. Hpb 19: S41-S42, 2017

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place. Annals of Surgery 262(2): 384-388, 2015

Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy 2019, 2019

EUS diagnosis of cystic pancreatic neuroendocrine tumors. Videogie 3(3): 106-108, 2018

Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis. Rofo 182(2): 175-177, 2010

Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?. Journal of Gastrointestinal Surgery 6(1): 66-74, 2002

EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy 40(7): 602-605, 2008

Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. American Journal of Surgical Pathology 36(11): 1666-1673, 2013

Cystic trophoblastic tumor A favorable histologic lesion in post-chemotherapy resections of patients with testicular germ cell tumors. Laboratory Investigation 81(1): 104A, January, 2001

Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis. Cancer Cytopathology 122(6): 435-444, 2014

Cystic pancreatic neuroendocrine tumors: To date a diagnostic challenge. International Journal of Surgery 21 Suppl 1: S44-S49, 2016

Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumors. Pancreatology 2018, 2018

Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World Journal of Gastrointestinal Surgery 7(4): 52-59, 2015

Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy 45(3): 189-194, 2013

Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: A CT and pathology correlation study. Pancreatology 17(4): 605-610, 2017